Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sol-Gel Technologies ( (SLGL) ) has provided an update.
Sol-Gel Technologies Ltd. has announced a Special Meeting of Shareholders set for April 1, 2025, to vote on two significant proposals. The first proposal involves approving a reverse share split within a specified range, while the second seeks to renew an updated compensation policy for the company’s officers and directors in compliance with Israeli law. These initiatives are intended to strengthen the company’s financial structure and ensure adherence to regulatory standards, reflecting strategic moves to enhance shareholder value and governance.
More about Sol-Gel Technologies
Sol-Gel Technologies Ltd. operates in the pharmaceutical industry, focusing on the development of topical dermatological drug products. The company is based in Ness Ziona, Israel, and is known for its innovative use of sol-gel technology to improve the efficacy and safety of topical medications.
YTD Price Performance: -39.90%
Average Trading Volume: 553,370
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $16.99M
See more data about SLGL stock on TipRanks’ Stock Analysis page.